A comprehensive view of respiratory / lung health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
State, county health officials investigate outbreak of fungal disease associated with Billerud's Escanaba paper mill in Michigan, as number of blastomycosis cases among workers climbs to 53; federal NIOSH agency to conduct health hazard study of employees
Published:
March 27, 2023
by MLive.com
|
AstraZeneca to triple its R&D investment in China, hire over 900 R&D personnel in the country; AstraZeneca to offer at least 15 new drugs in Chinese market by 2030, including oncology, respiratory disease, immunization, vaccines, rare disease drugs
Published:
March 27, 2023
by ForeignAffairs.co.nz
|
Health officials identify 35 cases of blastomycosis among workers at Billerud paper mill in Escanaba, Michigan, await results for nine more cases; 'exceedingly rare' fungal disease infects lungs, grows in moist soil, decomposing matter like wood, leaves
Published:
March 20, 2023
by MLive.com
|
Lung Cancer Research Foundation partners with Daiichi Sankyo, AstraZeneca to fund up to three research grants focused on antibody drug conjugates to treat lung cancer; grants to support research into HER2 directed and TROP2 directed ADCs
Published:
March 16, 2023
by Associated Press
|
European Patent Office Releases Eli Lilly and Company's Patent Application for Pan-ELR+ CXC Chemokine Antibodies for the Treatment of Respiratory Disease
Published:
March 15, 2023
by Pharmaceutical Patent News
|
Ask us about our Health Care Sector market view
Trending Chart
Interactive chart with headline count